Innocan Pharma Collaborates with Animal Sanctuary to Provide Pain Relief with LPT-CBD Injection

Innocan Pharma's Compassionate Initiative

Innocan Pharma Corporation, a key player in the pharmaceutical and biotechnology sectors, is making notable strides in animal welfare by partnering with Freedom Farm, a sanctuary dedicated to rescuing and rehabilitating animals abandoned due to physical disabilities and medical conditions. This initiative leverages Innocan’s innovative long-acting injectable LPT-CBD to administer relief to animals suffering from chronic pain, particularly focusing on the well-being of those in desperate need.

A Sanctuary for Injured Animals

Freedom Farm is known for its commitment to providing a safe haven for animals that have been cast aside by industrial farming operations. Their mission is to care for animals like Billy and Dror, two goats who faced severe skeletal deformities that resulted in debilitating pain and hindered their everyday activities. These goats have become emblematic of the positive impact LPT-CBD can have when provided through Innocan’s injection regimen, dispelling the notion that suffering animals are beyond help.

For over two years, Billy and Dror have received the LPT-CBD treatment, which involves a single subcutaneous injection every six to nine weeks. Reports from caregivers indicate a significant reduction in their pain levels, enhanced mobility, and an overall improvement in their quality of life. These advancements highlight the transformation possible through dedicated care enabled by Innocan’s science-driven approach.

Transformative Results from LPT-CBD

LPT-CBD is a specialized liposomal drug designed for chronic pain management through a controlled release mechanism of synthetic CBD. The results from Billy and Dror’s treatments affirm the potential of this innovative product. As they actively engage with their environment, their story illustrates the profound difference that proper medical intervention can make.

"Billy and Dror’s lives have been completely turned around since starting LPT-CBD treatment," stated Meital Ben Ari, co-founder of Freedom Farm. The reduction in their pain and the return of their ability to socialize exemplifies the relief that can be attained, akin to a miracle for those who care for these animals.

Innocan’s commitment goes beyond merely providing a product; it embodies a vision to foster a compassionate relationship between humans and animals. Iris Bincovich, the CEO of Innocan Pharma, underscores this mission as they strive to enrich the lives of both domesticated and farm animals while promoting ethical practices within the sector.

Commitment to Sustainable Impact

"It’s not just about alleviating pain; it’s about restoring dignity and happiness to their lives," Bincovich remarked. The collaboration with Freedom Farm highlights the company's dedication to ensuring that every creature has the opportunity to experience a fulfilling and pain-free life.

Eyal Kalo, Vice President of Research and Development, adds, "Clinical feedback from these compassionate cases supports the efficacy of LPT-CBD across the board. Our extensive pre-clinical data and feedback from real-world applications showcase the transformative capabilities of our technology in managing pain, not just in animals but potentially in humans, too."

Innocan Pharma continues to pave the way for innovative treatments in both pharmaceuticals and healthcare, aiming to create products that cater to wellness beyond traditional practices. By combining research with a deep-rooted care for animals, Innocan exemplifies what it means to be a socially responsible and forward-thinking entity.

For further insights about Innocan Pharma and their engagements in the pharmaceutical and wellness sectors, you can visit their website at Innocan Pharma. As they continue to broaden their impact, the hope is to inspire others in the scientific community to explore compassionate avenues in pain management and animal welfare.

Innocan's dedication not only represents a significant advancement in veterinary care but also reinforces the growing movement towards humane treatment of all living beings, encouraging a collaborative approach to health and well-being.